Document is current
Any future updates will be listed below
-
Authors
Corbaux, Pauline
Bainaud, Matthieu
Rousseau, Adrien
Try, Mélanie
Saillant, Arnaud
Lafargue, Marie-Camille
Stocker, Nicolas
Afchain, Pauline
Jamelot, Mathieu
Isnard-Bagnis, Corinne
Campedel, Luca
Delaye, Matthieu
- License Information
-
More Information
Article History
Received: 31 January 2024
Accepted: 23 October 2024
First Online: 1 November 2024
Declarations
:
: This study was conducted in accordance with the principles of the Declaration of Helsinki and was approved by the Research Ethics Committee of Sorbonne Université on July 13th, 2021 (CER-2020–109). All participants were informed of the study purpose by an information note, and provided informed oral consent.
: P Corbaux received travel support from Daiichi-Sankyo/Astrazeneca and Novartis. C. Isnard-Bagnis served as a consultant, received honorarium and travel reimbursements from Astrazeneca, Baxter and GSK. L. Campedel served as a consultant, received honorarium and travel reimbursements from Pfizer, BMS, MSD, Bayer, Janssen and Ipsen. O. Afchain declares disclosures with IPSEN M. Jamelot declares disclosures with BMS, Astellas, IPSEN. Other authors have nothing to disclose.
